Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Allergen Extract. Determination of the Allergenic Potency in Vivo Histamine Equivalent Units (HEP)
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2018
At a glance
- Drugs MM 09 (Primary) ; MM 09 (Primary) ; Histamine dihydrochloride
- Indications Hypersensitivity
- Focus Pharmacodynamics
- Sponsors Inmunotek
- 07 Aug 2018 Status changed from recruiting to completed.
- 27 Feb 2018 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018.
- 27 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.